Andrew C Pawlowski
Overview
Explore the profile of Andrew C Pawlowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
3904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morales D, Robinson A, Pawlowski A, Ark C, Kelliher J, Junier P, et al.
Front Microbiol
. 2022 Jun;
13:892227.
PMID: 35722318
Several bacteria have long been known to interact intimately with fungi, but molecular approaches have only recently uncovered how cosmopolitan these interactions are in nature. Currently, bacterial-fungal interactions (BFI) are...
2.
Culp E, Sychantha D, Hobson C, Pawlowski A, Prehna G, Wright G
Nat Microbiol
. 2022 Mar;
7(3):451-462.
PMID: 35246663
The caseinolytic protease (ClpP) is part of a highly conserved proteolytic complex whose disruption can lead to antibacterial activity but for which few specific inhibitors have been discovered. Specialized metabolites...
3.
Robinson-McCarthy L, Mijalis A, Filsinger G, de Puig H, Donghia N, Schaus T, et al.
Microbiol Spectr
. 2021 Sep;
9(2):e0031321.
PMID: 34523989
The coronavirus disease 2019 (COVID-19) pandemic has brought about the unprecedented expansion of highly sensitive molecular diagnostics as a primary infection control strategy. At the same time, many laboratories have...
4.
Liu S, Punthambaker S, Iyer E, Ferrante T, Goodwin D, Furth D, et al.
Nucleic Acids Res
. 2021 Mar;
49(10):e58.
PMID: 33693773
We present barcoded oligonucleotides ligated on RNA amplified for multiplexed and parallel insitu analyses (BOLORAMIS), a reverse transcription-free method for spatially-resolved, targeted, in situ RNA identification of single or multiple...
5.
Robinson-McCarthy L, Mijalis A, Filsinger G, de Puig H, Donghia N, Schaus T, et al.
Science
. 2021 Jan;
371(6526):244-245.
PMID: 33446547
No abstract available.
6.
Alcock B, Raphenya A, Lau T, Tsang K, Bouchard M, Edalatmand A, et al.
Nucleic Acids Res
. 2019 Oct;
48(D1):D517-D525.
PMID: 31665441
The Comprehensive Antibiotic Resistance Database (CARD; https://card.mcmaster.ca) is a curated resource providing reference DNA and protein sequences, detection models and bioinformatics tools on the molecular basis of bacterial antimicrobial resistance...
7.
Culp E, Yim G, Waglechner N, Wang W, Pawlowski A, Wright G
Nat Biotechnol
. 2019 Sep;
37(10):1149-1154.
PMID: 31501558
Actinobacteria, which are one of the largest bacterial phyla and comprise between 13 and 30% of the soil microbiota, are the main source of antibiotic classes in clinical use. During...
8.
Yim G, Wang W, Pawlowski A, Wright G
Antimicrob Agents Chemother
. 2018 Oct;
62(12).
PMID: 30275088
Glycopeptide antibiotics (GPAs) include clinically important drugs used for the treatment of infections caused by Gram-positive pathogens. These antibiotics are specialized metabolites produced by several genera of actinomycete bacteria. While...
9.
Pawlowski A, Stogios P, Koteva K, Skarina T, Evdokimova E, Savchenko A, et al.
Nat Commun
. 2018 Jan;
9(1):112.
PMID: 29317655
The production of antibiotics by microbes in the environment and their use in medicine and agriculture select for existing and emerging resistance. To address this inevitability, prudent development of antibiotic...
10.
Pawlowski A, Westman E, Koteva K, Waglechner N, Wright G
ISME J
. 2017 Dec;
12(3):885-897.
PMID: 29259290
The ecology of antibiotic resistance involves the interplay of a long natural history of antibiotic production in the environment, and the modern selection of resistance in pathogens through human use...